Paul A. LaViolette, age 63, has been a director of the Company since July 2020. Mr. LaViolette brings 40 years of experience in global medical technology, operating leadership and investing. He is currently the Managing Partner and Chief Operating Officer of SV Health Investors LLC, a specialist healthcare fund management company, and is currently investing in portfolio companies for its Medtech Convergence Fund. Prior to that, he held various positions during his 15 years with Boston Scientific Corporation (BSC), including Chief Operating Officer, President, Cardiology and President, International. While at BSC, Mr. LaViolette integrated dozens of acquisitions and led extensive product development, operations, and worldwide commercial organizations. Before BSC, he held marketing and general management positions at C.R. Bard Inc. and various marketing roles at Kendall, Inc. Mr. LaViolette currently serves as the Chairman of the Board for TransEnterix, Inc. and Misonix, Inc., both public companies, and on the boards of several other early and growth stage private medical companies. Additionally, Mr. LaViolette currently serves on the board and was recently the two-term chairman of the Medical Device Manufacturers Association and is Chairman of the Innovation Advisory Board for the Mass General Brigham Health System. He has also served on the Board of Directors and Executive Committee of the Advanced Medical Technology Association (AdvaMed) and chaired all three major policy committees over a 10-year period. Mr. LaViolette earned his MBA from Boston College and his Bachelor of Arts in Psychology from Fairfield University.